(Total Views: 473)
Posted On: 03/31/2022 12:15:35 PM
Post# of 148905
Yes but didn’t they say TNBC was a long shot for BTD. Basically we don’t have enough data for cancer. That’s how I heard it.
Doesn’t change that we need more trials, but why would Scott say some TNBC patients stoped getting Leronlimab after the trial was done once they went back and checked the information? Or he said something the the effect that not everyone was getting Leronlimab once it was done.
I’m confused as to why that would even happen to begin with.
Doesn’t change that we need more trials, but why would Scott say some TNBC patients stoped getting Leronlimab after the trial was done once they went back and checked the information? Or he said something the the effect that not everyone was getting Leronlimab once it was done.
I’m confused as to why that would even happen to begin with.
(2)
(0)Scroll down for more posts ▼
